Autoantibodies to Perilipin-1 Define a Subset of Acquired Generalized Lipodystrophy.


Journal

Diabetes
ISSN: 1939-327X
Titre abrégé: Diabetes
Pays: United States
ID NLM: 0372763

Informations de publication

Date de publication:
01 01 2023
Historique:
received: 03 01 2022
accepted: 06 06 2022
pmc-release: 01 01 2024
pubmed: 17 6 2022
medline: 23 12 2022
entrez: 16 6 2022
Statut: ppublish

Résumé

Acquired lipodystrophy is often characterized as an idiopathic subtype of lipodystrophy. Despite suspicion of an immune-mediated pathology, biomarkers such as autoantibodies are generally lacking. Here, we used an unbiased proteome-wide screening approach to identify autoantibodies to the adipocyte-specific lipid droplet protein perilipin 1 (PLIN1) in a murine model of autoimmune polyendocrine syndrome type 1 (APS1). We then tested for PLIN1 autoantibodies in human subjects with acquired lipodystrophy with two independent severe breaks in immune tolerance (including APS1) along with control subjects using a specific radioligand binding assay and indirect immunofluorescence on fat tissue. We identified autoantibodies to PLIN1 in these two cases, including the first reported case of APS1 with acquired lipodystrophy and a second patient who acquired lipodystrophy as an immune-related adverse event following cancer immunotherapy. Lastly, we also found PLIN1 autoantibodies to be specifically enriched in a subset of patients with acquired generalized lipodystrophy (17 of 46 [37%]), particularly those with panniculitis and other features of autoimmunity. These data lend additional support to new literature that suggests that PLIN1 autoantibodies represent a marker of acquired autoimmune lipodystrophies and further link them to a break in immune tolerance.

Identifiants

pubmed: 35709010
pii: 147096
doi: 10.2337/db21-1172
pmc: PMC9797316
doi:

Substances chimiques

Perilipin-1 0
Autoantibodies 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

59-70

Subventions

Organisme : NIAID NIH HHS
ID : P01 AI118688
Pays : United States
Organisme : NIDDK NIH HHS
ID : F30 DK123915
Pays : United States
Organisme : NINDS NIH HHS
ID : K99 NS117800
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH122471
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK123559
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIA AI001175
Pays : United States
Organisme : NIAID NIH HHS
ID : R37 AI097457
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK105448
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2022 by the American Diabetes Association.

Références

Nat Genet. 1997 Dec;17(4):393-8
pubmed: 9398839
JCI Insight. 2016 Aug 18;1(13):
pubmed: 27588307
N Engl J Med. 2019 Jul 4;381(1):89-91
pubmed: 31269373
Proc Natl Acad Sci U S A. 2001 May 22;98(11):6494-9
pubmed: 11371650
Diabetes. 2015 Jan;64(1):299-310
pubmed: 25114292
Medicine (Baltimore). 2004 Jan;83(1):18-34
pubmed: 14747765
Nat Rev Immunol. 2016 Apr;16(4):247-58
pubmed: 26972725
J Am Acad Dermatol. 2006 Dec;55(6):947-50
pubmed: 17097389
N Engl J Med. 2011 Feb 24;364(8):740-8
pubmed: 21345103
J Endocrinol Invest. 2019 Jan;42(1):61-73
pubmed: 29704234
Science. 2020 Feb 21;367(6480):
pubmed: 32079746
J Clin Endocrinol Metab. 2016 Apr;101(4):1344-7
pubmed: 26891119
Elife. 2020 May 15;9:
pubmed: 32410729
Nat Commun. 2021 Feb 17;12(1):1096
pubmed: 33597545
J Clin Endocrinol Metab. 2011 Nov;96(11):3313-25
pubmed: 21865368
Genome Res. 2014 Dec;24(12):1918-31
pubmed: 25224068
Diabetes Care. 2019 Oct;42(10):2008-2010
pubmed: 31434650
Endocrinol Metab Clin North Am. 2016 Dec;45(4):783-797
pubmed: 27823605
Front Immunol. 2018 Sep 19;9:2142
pubmed: 30283460
Brain Commun. 2020 Aug 03;2(2):fcaa059
pubmed: 32954318
J Clin Endocrinol Metab. 2016 Dec;101(12):4500-4511
pubmed: 27710244
J Clin Endocrinol Metab. 2019 Aug 1;104(8):3245-3248
pubmed: 30779841
Curr Opin Genet Dev. 2007 Jun;17(3):193-200
pubmed: 17466510
N Engl J Med. 2018 Mar 22;378(12):1132-1141
pubmed: 29562162
J Clin Res Pediatr Endocrinol. 2019 Aug 22;12(1):17-28
pubmed: 31434462
Mol Cell Biochem. 2009 Jun;326(1-2):15-21
pubmed: 19116774
Br J Dermatol. 2020 Feb;182(2):477-480
pubmed: 31077337
N Engl J Med. 2018 Jan 11;378(2):158-168
pubmed: 29320654
Science. 2002 Nov 15;298(5597):1395-401
pubmed: 12376594
N Engl J Med. 2019 Jul 4;381(1):47-54
pubmed: 31269365
Medicine (Baltimore). 2003 Mar;82(2):129-46
pubmed: 12640189

Auteurs

Caleigh Mandel-Brehm (C)

Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA.

Sara E Vazquez (SE)

Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA.
Diabetes Center, University of California, San Francisco, San Francisco, CA.

Christopher Liverman (C)

Department of Pathology, University of California, San Francisco, San Francisco, CA.

Mickie Cheng (M)

Diabetes Center, University of California, San Francisco, San Francisco, CA.

Zoe Quandt (Z)

Diabetes Center, University of California, San Francisco, San Francisco, CA.
Department of Medicine, University of California, San Francisco, San Francisco, CA.

Andrew F Kung (AF)

Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA.

Audrey Parent (A)

Diabetes Center, University of California, San Francisco, San Francisco, CA.

Brenda Miao (B)

Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA.
Diabetes Center, University of California, San Francisco, San Francisco, CA.

Emmanuel Disse (E)

Endocrinology Diabetology and Nutrition Department, Lyon Sud Hospital, Hospices Civils de Lyon, Pierre-Bénite, France.
ImmuCare, Cancer Institute of Hospices Civils de Lyon (IC-HCL), Lyon, France.

Christine Cugnet-Anceau (C)

Endocrinology Diabetology and Nutrition Department, Lyon Sud Hospital, Hospices Civils de Lyon, Pierre-Bénite, France.
ImmuCare, Cancer Institute of Hospices Civils de Lyon (IC-HCL), Lyon, France.

Stéphane Dalle (S)

ImmuCare, Cancer Institute of Hospices Civils de Lyon (IC-HCL), Lyon, France.
Dermatology Department, Lyon Sud Hospital, Hospices Civils de Lyon, Pierre-Bénite, France.

Elizaveta Orlova (E)

Endocrinology Research Centre, Institute of Paediatric Endocrinology, Moscow, Russia.

Elena Frolova (E)

National Medical Research Center of Children's Health, Moscow, Russia.

Diana Alba (D)

Diabetes Center, University of California, San Francisco, San Francisco, CA.
Department of Medicine, University of California, San Francisco, San Francisco, CA.

Aaron Michels (A)

Barbara Davis Center for Childhood Diabetes, University of Colorado School of Medicine, Aurora, CO.

Bergithe E Oftedal (BE)

University of Bergen, Bergen, Norway.
Department of Medicine, Haukeland University Hospital, Bergen, Norway.

Michail S Lionakis (MS)

Fungal Pathogenesis Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.

Eystein S Husebye (ES)

Department of Medicine, Haukeland University Hospital, Bergen, Norway.
Department of Clinical Science and K.G. Jebsen Center for Autoimmune Disorders, University of Bergen, Bergen, Norway.

Anil K Agarwal (AK)

Division of Nutrition and Metabolic Diseases, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX.

Xilong Li (X)

Department of Population and Data Sciences, UT Southwestern Medical Center, Dallas, TX.

Chengsong Zhu (C)

Department of Immunology, UT Southwestern Medical Center, Dallas, TX.

Quan Li (Q)

Department of Immunology, UT Southwestern Medical Center, Dallas, TX.

Elif Oral (E)

Division of Metabolism, Endocrinology & Diabetes and Caswell Diabetes Institute, University of Michigan, Ann Arbor, MI.

Rebecca Brown (R)

Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD.

Mark S Anderson (MS)

Diabetes Center, University of California, San Francisco, San Francisco, CA.
Department of Medicine, University of California, San Francisco, San Francisco, CA.

Abhimanyu Garg (A)

Division of Nutrition and Metabolic Diseases, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX.

Joseph L DeRisi (JL)

Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA.
Chan Zuckerberg Biohub, San Francisco, CA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH